搜索医生

Amanika Kumar, M.D.

  1. Gynecologic Oncologist
预约门诊

出版物

  1. Ostby SA, Narasimhulu D, Ochs Kinney MA, Cliby W, Langstraat C, Bakkum-Gamez JN, Ishitani K, Lemens M, Martin P, Borah B, Moriarty J, Glaser G, Kumar A, Arendt KW, Dowdy SC. Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial. Gynecol Oncol. 2024 Nov; 190:11-17 Epub 2024 Aug 07
    View PubMed
  2. Mokshagundam S, McGree ME, Tapia AL, Fought AJ, Ishitani KP, Lee MK, Dowdy SC, Yadav S, Pachman DR, Kumar A. Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2024 Nov; 190:230-235 Epub 2024 Sept 05
    View PubMed
  3. Howlett LN, Fadadu PP, Grcevich LO, Fought AJ, McGree ME, Giannini A, Butler KA, Tortorella L, Marnholtz AA, Haddock MG, Garda AE, Langstraat CL, Dowdy SC, Kumar A. Intraoperative Radiation Therapy for Recurrent Cervical and Endometrial Cancer: Predicting Morbidity and Mortality in a Contemporary Cohort. Cancers (Basel). 2024 Oct 28; 16 (21)
    View PubMed
  4. Caruso G, Langstraat CL, Kumar A, McGree ME, Fought AJ, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby WA. Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer. Gynecol Oncol. 2024 Oct 3; 191:86-94 Epub 2024 Oct 03
    View PubMed
  5. Warring S, Yost KJ, Cheville AL, Dowdy SC, Faubion SS, Kumar A, Lemens MA, Van Oort CC, Fought AJ, Mc Gree ME, Mariani A, Glaser G. The Quality of Life after Endometrial Cancer Study: Baseline Characteristics and Patient-Reported Outcomes. Curr Oncol. 2024 Sep 17; 31 (9):5557-5572 Epub 2024 Sept 17
    View PubMed
  6. Dinoi G, Garzon S, Weaver A, McGree M, Glaser G, Langstraat C, Kumar A, Weroha J, Garda AE, Shahi M, Palmieri E, Scambia G, Fanfani F, Mariani A. How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer. Int J Gynecol Cancer. 2024 Sep 2; 34 (9):1389-1398 Epub 2024 Sept 02
    View PubMed
  7. Fumagalli D, Sonik R, De Vitis LA, Rossi V, Bazzurini L, McGree ME, Fought AJ, Mariani A, Cliby WA, Kumar A. Evaluating nutrition in advanced ovarian cancer: which biomarker works best? Gynecol Oncol. 2024 Sep; 188:97-102 Epub 2024 June 28
    View PubMed
  8. Sylvester MA, Kumar A, Baban FS, De Vitis LA. Clear cell adenocarcinoma of Mullerian origin in a patient with germline SMARCA4 mutation. Int J Gynecol Cancer. 2024 Aug 5; 34 (8):1302-1304 Epub 2024 Aug 05
    View PubMed
  9. Dinoi G, Ghoniem K, Huang Y, Zanfagnin V, Cucinella G, Langstraat C, Glaser G, Kumar A, Weaver A, McGree M, Fanfani F, Scambia G, Mariani A. Endometrial cancer with positive sentinel lymph nodes: pathologic characteristics of metastases as predictors of extent of lymphatic dissemination and prognosis. Int J Gynecol Cancer. 2024 Aug 5; 34 (8):1172-1182 Epub 2024 Aug 05
    View PubMed
  10. Mohammad A, Ainio C, Narasimhulu DM, McGree M, Weaver AL, Kumar A, Garbi A, Mariani A, Aletti G, Multinu F, Langstraat C, Cliby W. Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes. Int J Gynecol Cancer. 2024 Aug 5; 34 (8):1240-1245 Epub 2024 Aug 05
    View PubMed
  11. Merrell KW, Konney TO, Acheamfour O, Lucido J, Aduse-Poku AY, Kumar A, Ansah MB, Amankwa AT, Shumway D, Awittor FK, Badu-Peprah A, Fonkoua LAAK, Hendrickson AEW, Boakye E, Adjei EK, Kyei I, Kemper K, Rank M, Peethambaram PP, Spangenberg K, Sorenson K, Hearrold M, Garda A, Graham R, Lang K, Adom J, Achiaa R, Jakub J, Amo BD, Osei-Bonsu E, Camacho R, Addison ECDK. Participant Evaluation of a Multi-disciplinary Oncology Preceptorship Training Program for Oncology Health Professionals from Kumasi, Ghana. J Cancer Educ. 2024 Aug; 39 (4):360-367 Epub 2024 Mar 20
    View PubMed
  12. Kalogera E, Nevala WK, Finnes HD, Suman VJ, Schimke JM, Strand CA, Kottschade LA, Kudgus RA, Buhrow SA, Becher LR, Geng L, Glaser GE, Grudem ME, Jatoi A, Klampe CM, Kumar A, Langstraat CL, McWilliams RR, Wahner Hendrickson AE, Weroha SJ, Yan Y, Reid JM, Markovic SN, Block MS. A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clin Cancer Res. 2024 Jun 14; 30 (12):2623-2635
    View PubMed
  13. Glaser GE, Maddy B, Kumar A, Ishitani K, Lemens MA, Hanson K, Moyer AM, Habermann E, Dowdy SC. Impact of pharmacogenomic profiles on post-surgical pain following laparotomy for gynecologic pathology. Gynecol Oncol. 2024 Apr; 183:9-14 Epub 2024 Mar 12
    View PubMed
  14. Grant P, Quinn M, O'Neill H, Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching PA, Lambrechts D, Garcia MJ, Rodriguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, Kjaer SK, Jensen A, Hogdall E, Goode EL, Cliby WA, Kumar A, Wang C, Cunningham JM, Winham SJ, Monteiro AN, Schildkraut JM, Cramer DW, Terry KL, Titus L, Bjorge L, Thomsen LCV, Pejovic T, Hogdall CK, McNeish IA, May T, Huntsman DG, Pfisterer J, Canzler U, Park-Simon TW, Schroder W, Belau A, Hanker L, Harter P, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Baumann K, Hilpert F, Burges A, Winterhoff B, Schurmann P, Speith LM, Hillemanns P, Berchuck A, Johnatty SE, Ramus SJ, Chenevix-Trench G, Pharoah PDP, Dork T, Heitz F, AOCS Group//OPAL Study Group. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. NPJ Genom Med. 2024 Mar 5; 9 (1):19 Epub 2024 Mar 05
    View PubMed
  15. Loverro M, Aloisi A, Tortorella L, Aletti GD, Kumar A. Trends and current aspects of reconstructive surgery for gynecological cancers. Int J Gynecol Cancer. 2024 Mar 4; 34 (3):426-435 Epub 2024 Mar 04
    View PubMed
  16. Chauhan S, Langstraat CL, Fought AJ, McGree ME, Cliby WA, Kumar A. Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2024 Jan; 180:126-131. Epub 2023 Dec 12.
    View PubMed
  17. Shah R, Polen-De C, McGree M, Fought A, Kumar A. Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia. Curr Oncol. 2023 Oct 27; 30 (11):9501-9513
    View PubMed
  18. Vu JA, Thompson WS, Klinkner DB, Chattha A, Wick M, Case EJ, Collura C, Kumar A. Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective. Gynecol Oncol Rep. 2023 Oct; 49:101261 Epub 2023 Aug 18
    View PubMed
  19. Young MC, Bhandarkar AR, Portela RC, Jarrah R, Bydon M, Clapp B, Kumar A, Ghanem OM. Bariatric surgery reduces odds of perioperative complications after inpatient hysterectomy: Analysis from a national database, 2016 to 2018. Surgery. 2023 Oct; 174 (4):766-773 Epub 2023 July 27
    View PubMed
  20. Tabiei A, Stulak JM, Cifuentes S, Kumar A, DeMartino RR. Removal of intracaval and intracardiac leiomyoma in a 49-year-old woman. J Vasc Surg Cases Innov Tech. 2023 Sep; 9 (3):101239 Epub 2023 June 02
    View PubMed
  21. Shafa A, Watkins AB, McGree ME, Weroha SJ, Wahner Hendrickson AE, Block MS, Langstraat CL, McBane RD 2nd, Bakkum-Gamez JN, Kumar A. Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Gynecol Oncol. 2023 Sep; 176:36-42. Epub 2023 Jul 11.
    View PubMed
  22. Dinoi G, Multinu F, Yost K, AlHilli M, Larish A, Langstraat C, Kumar A, Weaver AL, McGree M, Cheville A, Dowdy S, Mariani A, Glaser G. Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes. Int J Gynecol Cancer. 2023 Aug 07; 33(8):1227-1236.
    View PubMed
  23. Playdon MC, Hardikar S, Karra P, Hoobler R, Ibele AR, Cook KL, Kumar A, Ippolito JE, Brown JC. Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities. J Natl Cancer Inst Monogr. 2023 May 4; 2023 (61):68-76
    View PubMed
  24. Kung CP, Skiba MB, Crosby EJ, Gorzelitz J, Kennedy MA, Kerr BA, Li YR, Nash S, Potiaumpai M, Kleckner AS, James DL, Coleman MF, Fairman CM, Galvan GC, Garcia DO, Gordon MJ, His M, Hornbuckle LM, Kim SY, Kim TH, Kumar A, Mahe M, McDonnell KK, Moore J, Oh S, Sun X, Irwin ML. Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022. J Natl Cancer Inst Monogr. 2023 May 4; 2023 (61):149-157
    View PubMed
  25. Polen-De C, Giri S, Fadadu P, Weaver A, Mcgree ME, Moynagh M, Takahashi N, Jatoi A, Lebrasseur NK, Cliby W, Williams G, Kumar A. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer. J Natl Cancer Inst Monogr. 2023 May 04; 2023(61):43-48.
    View PubMed
  26. Mohammad A, Ainio C, Narasimhulu DM, McGree M, Weaver AL, Kumar A, Garbi A, Mariani A, Aletti G, Multinu F, Langstraat C, Cliby W. Comparison of the Contracted Accordion, Expanded Accordion, and Clavien-Dindo complication grading scales after ovarian cancer cytoreduction. Int J Gynecol Cancer. 2023 May 01; 33(5):727-733.
    View PubMed
  27. Xu C, Garda AE, Kumar A. R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond. Curr Treat Options Oncol. 2023 Apr; 24 (4):262-273 Epub 2023 Feb 27
    View PubMed
  28. Narasimhulu DM, Fagotti A, Scambia G, Weaver AL, McGree M, Quagliozzi L, Langstraat C, Kumar A, Cliby W. Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer. Int J Gynecol Cancer. 2023 Jan 3; 33 (1):83-88 Epub 2023 Jan 03
    View PubMed
  29. Cummings P, Kumar A. Double-Minority: More on How Intersectional Identities Impact Health Care. Acad Med. 2022 Dec 1; 97 (12):1727 Epub 2022 Nov 23
    View PubMed
  30. Dholakia J, Lee YW, Lu KH, Huh WK, Yamada SD, Fuh KC, Kumar AS, Liang MI, Nair N, Kim KH. Identity-related experiences of Asian American trainees in gynecologic oncology. Gynecol Oncol Rep. 2022 Dec; 44:101097 Epub 2022 Nov 06
    View PubMed
  31. Kumar A, Wang C, Sheedy SP, McCauley BM, Winham SJ, Ramus SJ, Anglesio MS, Kim B, Torres D, Keeney GL, Cliby WA, Goode EL. Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. Gynecol Oncol. 2022 Sep; 166 (3):508-514 Epub 2022 Aug 02
    View PubMed
  32. Robinson KE, Tahbouh Amawi AD, Venkatesh SK, Torres-Mora J, West E, Kumar A. Vulvar glomangioma: A case report and literature review. Gynecol Oncol Rep. 2022 Aug; 42:101034 Epub 2022 June 24
    View PubMed
  33. Polen-De C, Fadadu P, Weaver AL, Moynagh M, Takahashi N, Jatoi A, LeBrasseur NK, McGree M, Cliby W, Kumar A. Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. Int J Gynecol Cancer. 2022 Jun 9 Epub 2022 June 09
    View PubMed
  34. Garzon S, Mariani A, Day CN, Habermann EB, Langstraat C, Glaser G, Kumar A, Casarin J, Uccella S, Ghezzi F, Larish A. Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study. Int J Gynecol Cancer. 2022 Jan; 32 (1):28-40 Epub 2021 Nov 08
    View PubMed
  35. Polen-De C, Langstraat C, Asiedu GB, Jatoi A, Kumar A. Advanced ovarian cancer patients identify opportunities for prehabilitation: A qualitative study. Gynecol Oncol Rep. 2021 May; 36:100731 Epub 2021 Feb 19
    View PubMed
  36. Narasimhulu DM, Block MS, Weaver AL, McGree M, Kumar A, Langstraat C, Petersen I, Mariani A, Glaser G. Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer. Int J Gynecol Cancer. 2021 May; 31 (5):702-708 Epub 2021 Mar 26
    View PubMed
  37. Narasimhulu DM, Thannickal A, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy. Gynecol Oncol. 2021 Mar; 160 (3):681-687 Epub 2020 Dec 31
    View PubMed
  38. Moynagh MR, Dowdy SC, Welch B, Glaser GE, Schmitz JJ, Jatoi A, Langstraat CL, Block MS, Kurup AN, Kumar A. Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program. Gynecol Oncol. 2021 Mar; 160 (3):835-843 Epub 2020 Dec 30
    View PubMed
  39. Glaser G, Dinoi G, Multinu F, Yost K, Al Hilli M, Larish A, Kumar A, McGree M, Weaver AL, Cheville A, Dowdy S, Mariani A. Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer. Int J Gynecol Cancer. 2021 Jan; 31(1):85-91. Epub 2020 Nov 26.
    View PubMed
  40. Block MS, Dietz AB, Gustafson MP, Kalli KR, Erskine CL, Youssef B, Vijay GV, Allred JB, Pavelko KD, Strausbauch MA, Lin Y, Grudem ME, Jatoi A, Klampe CM, Wahner-Hendrickson AE, Weroha SJ, Glaser GE, Kumar A, Langstraat CL, Solseth ML, Deeds MC, Knutson KL, Cannon MJ. Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nat Commun. 2020 Oct 14; 11(1):5173.
    View PubMed
  41. Larish A, Kumar A, Weaver A, Mariani A. Impact of hysteroscopy on course of disease in high-risk endometrial carcinoma. Int J Gynecol Cancer. 2020 Oct; 30 (10):1513-1519 Epub 2020 Aug 26
    View PubMed
  42. Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, Langstraat CL, Block MS, Kumar A. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020 Sep; 158 (3):646-652 Epub 2020 June 06
    View PubMed
  43. Yang J, Delara R, Ghaith S, Newman H, Magrina J, Butler K, Kumar A, Dinh T, Chen L, Magtibay P. Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 2020 Sep; 158 (3):555-561 Epub 2020 July 03
    View PubMed
  44. Schafer MJ, Zhang X, Kumar A, Atkinson EJ, Zhu Y, Jachim S, Mazula DL, Brown AK, Berning M, Aversa Z, Kotajarvi B, Bruce CJ, Greason KL, Suri RM, Tracy RP, Cummings SR, White TA, LeBrasseur NK. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight. 2020 Jun 18; 5 (12) Epub 2020 June 18
    View PubMed
  45. Narasimhulu DM, Cope A, Riaz IB, Petersen I, Cilby W, Langstraat C, Glaser G, Kumar A, Cappuccio S, Murad MH, West C, Mariani A. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2020 Jun; 30 (6):797-805 Epub 2020 Mar 26
    View PubMed
  46. Narasimhulu DM, Kumar A, Weaver AL, Langstraat CL, Cliby WA. Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management. Gynecol Oncol. 2020 Jun; 157 (3):572-577 Epub 2020 Apr 01
    View PubMed
  47. Glaser GE, Kalogera E, Kumar A, Yi J, Destephano C, Ubl D, Glasgow A, Habermann E, Dowdy SC. Outcomes and patient perspectives following implementation of tiered opioid prescription guidelines in gynecologic surgery. Gynecol Oncol. 2020 May; 157 (2):476-481 Epub 2020 Feb 24
    View PubMed
  48. Kumar A, Cliby WA. Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery. Clin Obstet Gynecol. 2020 Mar; 63 (1):74-79
    View PubMed
  49. Stukan M, Bugalho A, Kumar A, Kowalewska J, Swietlik D, Buda N, Pietrzak-Stukan M, Dudziak M. Lung and Intercostal Upper Abdomen Ultrasonography for Staging Patients with Ovarian Cancer: A Method Description and Feasibility Study. Diagnostics (Basel). 2020 Feb 5; 10 (2) Epub 2020 Feb 05
    View PubMed
  50. Casarin J, Multinu F, Tortorella L, Cappuccio S, Weaver AL, Ghezzi F, Cilby W, Kumar A, Langstraat C, Glaser G, Mariani A. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes. Int J Gynecol Cancer. 2020 Jan; 30 (1):41-47 Epub 2019 Nov 27
    View PubMed
  51. Narasimhulu DM, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2019 Oct; 155(1):58-62. Epub 2019 Aug 08.
    View PubMed
  52. Kilts TP, Glaser GE, Langstraat CL, Kumar A, Weaver AL, Mc Gree ME, Gostout BS, Podratz KC, Dowdy SC, Cliby WA, Mariani A, Bakkum-Gamez JN. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer. Gynecol Oncol. 2019 Oct; 155 (1):21-26 Epub 2019 Aug 10
    View PubMed
  53. Littell RD, Kumar A, Einstein MH, Karam A, Bevis K. Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide. Gynecol Oncol. 2019 Oct; 155 (1):161-169 Epub 2019 Aug 16
    View PubMed
  54. Tortorella L, Casarin J, Multinu F, Cappuccio S, McGree ME, Weaver AL, Langstraat CL, Keeney GL, Kumar A, Melis GB, Angioni S, Scambia G, Mariani A, Glaser GE. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping. Gynecol Oncol. 2019 Oct; 155(1):34-38. Epub 2019 Aug 08.
    View PubMed
  55. Kumar A, Martin DP, Dhanorker SR, Brandt SR, Schroeder DR, Hanson AC, Cima RR, Dowdy SC. Improving the rate of surgical normothermia in gynecologic surgery. Gynecol Oncol. 2019 Sep; 154 (3):590-594 Epub 2019 July 05
    View PubMed
  56. Shafa A, Kumar A, Torres D, McKenzie TJ. Minimally Invasive Hysterectomy and Bariatric Surgery to Improve Endometrial Cancer Survivorship. Obstet Gynecol. 2019 Sep; 134 (3):570-572
    View PubMed
  57. Torres D, Shafa A, Klennert S, Hokenstad A, Bird M, Weinhold M, Mundi MS, Langstraat C, Kumar A. Using quality improvement to increase the awareness of obesity among endometrial cancer patients. Int J Gynecol Cancer. 2019 Jul; 29 (6):1010-1015 Epub 2019 June 14
    View PubMed
  58. Kumar A, Sheedy S, Kim B, Suidan R, Sarasohn DM, Nikolovski I, Lakhman Y, McGree ME, Weaver AL, Chi D, Cliby WA. Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease. Gynecol Oncol. 2019 Jul; 154(1):72-76. Epub 2019 Apr 16.
    View PubMed
  59. Mert I, Kumar A, Torres D, Huang Y, McGree ME, Weaver AL, Cliby WA. Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease? Gynecol Oncol. 2019 May; 153(2):238-241. Epub 2019 Mar 02.
    View PubMed
  60. Kumar A, Wallace SA, Cliby WA, Glaser GE, Mariani A, Leitao MM, Frumovitz M, Langstraat CL. Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol. 2019 May - Jun; 26 (4):727-732 Epub 2018 Aug 20
    View PubMed
  61. Yao T, DeJong SR, McGree ME, Weaver AL, Cliby WA, Kumar A. Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery. Gynecol Oncol. 2019 Apr; 153(1):68-73. Epub 2019 Jan 03.
    View PubMed
  62. Kumar A, Nesbitt KM, Bakkum-Gamez JN. Quality improvement in gynecologic oncology: Current successes and future promise. Gynecol Oncol. 2019 Mar; 152 (3):486-491
    View PubMed
  63. Kalogera E, Glaser GE, Kumar A, Dowdy SC, Langstraat CL. Enhanced Recovery after Minimally Invasive Gynecologic Procedures with Bowel Surgery: A Systematic Review. J Minim Invasive Gynecol. 2019 Feb; 26 (2):288-298 Epub 2018 Oct 24
    View PubMed
  64. Wagner BE, Langstraat CL, McGree ME, Weaver AL, Sarangi S, Mokri B, Dowdy SC, Cliby WA, Kumar A, Bakkum-Gamez JN. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer. Gynecol Oncol. 2019 Feb; 152(2):286-292. Epub 2018 Nov 22.
    View PubMed
  65. Torres D, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Wang C, Langstraat CL, Cliby WA. Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2019 Feb; 152(2):223-227. Epub 2018 Nov 28.
    View PubMed
  66. Casarin J, Multinu F, Pasupathy K, Weaver A, McGree M, Tortorella L, Torres D, Kumar A, Langstraat C, Huang Y, Ghezzi F, Mariani A, Glaser G. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging. Ann Surg Oncol. 2018 Nov; 25 (12):3692-3698 Epub 2018 Aug 16
    View PubMed
  67. Hinchcliff E, Green I, Destephano C, Cox M, Smink D, Kumar A, Hokenstad E, Bengtson J, Cohen SL. Visuospatial Aptitude Testing Differentially Predicts Simulated Surgical Skill. J Minim Invasive Gynecol. 2018 Sep - Oct; 25 (6):1044-1050 Epub 2018 Feb 05
    View PubMed
  68. Torres D, Wang C, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Konecny GE, Goode EL, Cliby WA. Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability. Gynecol Oncol. 2018 Aug; 150(2):227-232. Epub 2018 Jun 18.
    View PubMed
  69. Swanson CL, Kumar A, Maharaj JM, Kemppainen JL, Thomas BC, Weinhold MR, Slaby KM, Mara KC, Wick MJ, Bakkum-Gamez JN. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis. Gynecol Oncol. 2018 Apr; 149(1):121-126. Epub 2018 Feb 03.
    View PubMed
  70. Mert I, Kumar A, Sheedy SP, Weaver AL, McGree ME, Kim B, Cliby WA. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival. Gynecol Oncol. 2018 Jan; 148(1):68-73. Epub 2017 Nov 10.
    View PubMed
  71. Torres D, Kumar A, Wallace SK, Bakkum-Gamez JN, Konecny GE, Weaver AL, McGree ME, Goode EL, Cliby WA, Wang C. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer. Gynecol Oncol. 2017 Dec; 147(3):503-508. Epub 2017 Sep 28.
    View PubMed
  72. Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN. Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses. Gynecol Oncol. 2017 Dec; 147(3):514-520. Epub 2017 Sep 22.
    View PubMed
  73. Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer. Gynecol Oncol. 2017 Oct; 147(1):104-109. Epub 2017 Jul 19.
    View PubMed
  74. Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A. Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer. Anticancer Res. 2017 Jul; 37 (7):3673-3677
    View PubMed
  75. Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol. 2017 Apr; 145(1):21-26. Epub 2017 Jan 31.
    View PubMed
  76. Larish A, Kumar A, Kerr S, Langstraat C. Primary Gastric Choriocarcinoma Presenting as a Pregnancy of Unknown Location. Obstet Gynecol. 2017 Feb; 129 (2):281-284
    View PubMed
  77. Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016 Aug; 142 (2):311-6 Epub 2016 June 02
    View PubMed
  78. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
    View PubMed
  79. Janco JM, Kumar A, Weaver AL, McGree ME, Cliby WA. Performance of AGO score for secondary cytoreduction in a high-volume U.S. center. Gynecol Oncol. 2016 Apr; 141(1):140-7. Epub 2016 Feb 02.
    View PubMed
  80. Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2016 Jan; 140 (1):15-21 Epub 2015 Nov 02
    View PubMed
  81. Smits A, Lopes A, Das N, Kumar A, Cliby W, Smits E, Bekkers R, Massuger L, Galaal K. Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG. 2015 Sep 02.
    View PubMed
  82. Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015 May; 23 (5):1303-9 Epub 2014 Oct 23
    View PubMed
  83. Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014 Oct; 135(1):19-24. Epub 2014 Aug 07.
    View PubMed
  84. Weroha SJ, Becker MA, Enderica-Gonzalez S, Harrington SC, Oberg AL, Maurer MJ, Perkins SE, AlHilli M, Butler KA, McKinstry S, Fink S, Jenkins RB, Hou X, Kalli KR, Goodman KM, Sarkaria JN, Karlan BY, Kumar A, Kaufmann SH, Hartmann LC, Haluska P. Tumorgrafts as in vivo surrogates for women with ovarian cancer. Clin Cancer Res. 2014 Mar 01; 20(5):1288-97. Epub 2014 Jan 07.
    View PubMed
PST-20241758